Sun Pharma Q2 results: Net profit rises 2.6%, profitability takes a hit on declining US sales

Sun Pharmaceutical Industries Ltd. delivered on its quarterly profit in July-September 2025, helped by strong demand for its ...
InvestorsHub on MSN

Amgen Tops Q3 Expectations as Product Portfolio Strengthens; Shares Rise

Amgen (NASDAQ:AMGN) delivered better-than-expected third-quarter results on Tuesday, helped by strong product sales and ...

Palvella Therapeutics Announces New QTORIN™ Product Candidate, QTORIN™ Pitavastatin, for the Treatment of Disseminated Superficial Actinic Porokeratosis (DS…

DSAP is a premalignant, progressive disease characterized by numerous expanding lesions which significantly impact quality-of ...